Research materials,
clearly specified

A synthetic peptide fragment studied in laboratory models of cell signalling, tissue-response pathways and interactions involving the gastrointestinal environment. Research is preclinical and does not establish a treatment or approved human use.

A mitochondria-derived peptide investigated in experimental models of cellular energy sensing, glucose metabolism and metabolic signalling. Most evidence is laboratory or early-stage research, so findings should not be interpreted as proven health benefits.

A short synthetic peptide used in research concerning cellular ageing, oxidative stress and telomere-associated biology. Published work is limited and exploratory; it is not an established therapy and no clinical benefit is claimed.

A synthetic peptide studied in neuroscience models involving neurochemical signalling, stress response and cognitive pathways. Evidence varies by model and jurisdiction, and this catalogue description does not imply approved medical use.

A growth-hormone-releasing-factor analogue used by researchers to examine endocrine signalling and metabolic pathways. It is a regulated prescription medicine in some settings; laboratory discussion must not be treated as personal medical guidance.

A short peptide investigated for its role in reproductive and endocrine signalling, particularly pathways involving gonadotropin-releasing hormone. It is primarily a research reference here, without claims of therapeutic effect.

Sterile water containing a preservative, commonly used as a laboratory diluent where the applicable protocol and compatibility documentation permit. It has no independent therapeutic effect and must be handled according to the relevant technical instructions.

A naturally occurring cellular coenzyme central to redox reactions and energy metabolism. Laboratory research examines its roles in mitochondrial function, enzyme activity and cellular stress. This description does not support claims that supplementation treats disease.

A GLP-1 receptor agonist used in regulated medical contexts and studied in metabolic and appetite-signalling research. In the UK it is prescription-only; this catalogue profile is informational and not an offer for online supply.

A dual GIP/GLP-1 receptor agonist studied and medically regulated for specific approved indications. It is prescription-only in the UK and is displayed solely for scientific and regulatory reference, not offered for online supply.

An investigational multi-receptor agonist being evaluated in authorised clinical research. It is not authorised for routine UK use and is shown only as a scientific reference; no sale, quotation or therapeutic claim is provided.

Bremelanotide is a melanocortin-receptor agonist researched in neuroendocrine and sexual-response pathways. Regulatory status differs by country. This entry is informational only and is held from online supply pending classification review.

Human chorionic gonadotropin is a hormone involved in reproductive endocrine signalling and is used in regulated medical and laboratory contexts. In the UK it is prescription-only; this catalogue entry is documentation-only and not an offer for sale.

A synthetic melanocortin analogue investigated in experimental pigmentation and receptor-signalling research. It is unlicensed in the UK, has recognised safety concerns and is included only as a scientific reference, without online supply.